SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline vulnerabilities and quality-of-life (QoL) factors, beyond performance status, data ...

T-DM1 was tolerable in HER2-positive biliary tract adenocarcinoma but did not significantly improve progression-free survival ...

In the zanzalintinib plus atezolizumab and zanzalintinib groups, 39% and 51%, respectively, had an Eastern Cooperative Oncology Group Performance Status of one, patients had a median 2.5 and 3.0 ...